Risk factors and molecular mechanisms associated with trimethoprim–sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico

Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia

(2017) So Young Chong et al.   Microbial Drug Resistance

Comparisons between patients with trimethoprim–sulfamethoxazole-susceptible and trimethoprim–sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study

(2016) Ching-Hsun Wang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China

(2016) Li-Fen Hu et al.   PLoS One

The Efflux Pump SmeDEF Contributes to Trimethoprim-Sulfamethoxazole Resistance in Stenotrophomonas maltophilia

(2015) María Blanca Sánchez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Thesul1Gene inStenotrophomonas maltophiliaWith High-Level Resistance to Trimethoprim/Sulfamethoxazole

(2015) Hae-Sun Chung et al.   Annals of Laboratory Medicine

Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options

(2015) Ya-Ting Chang et al.   Frontiers in Microbiology

Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity

(2014) Samantha Flores-Treviño et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Risk Factors and Outcomes of Stenotrophomonas maltophilia Bacteraemia: A Comparison with Bacteraemia Caused by Pseudomonas aeruginosa and Acinetobacter Species

(2014) Go Hotta et al.   PLoS One

Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?

(2013) Sun Young Cho et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Expression of Sme Efflux Pumps and Multilocus Sequence Typing in Clinical Isolates ofStenotrophomonas maltophilia

(2012) Hye Hyun Cho et al.   Annals of Laboratory Medicine

Antimicrobial Susceptibilities of a Worldwide Collection of Stenotrophomonas maltophilia Isolates Tested against Tigecycline and Agents Commonly Used for S. maltophilia Infections

(2010) D. J. Farrell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Quadruplex real-time quantitative PCR assay for the detection of pathogens related to late-onset ventilator-associated pneumonia

(2010) Merab M. Rios-Licea et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Attributable mortality ofStenotrophomonas maltophiliainfections: a systematic review of the literature

(2009) Matthew E Falagas et al.   Future Microbiology

Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation

(2009) S.-J. Liaw et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS